文献
J-GLOBAL ID:201802281350837186
整理番号:18A0383564
チロシンキナーゼ阻害剤の時代における治療関連慢性骨髄性白血病の発生率と転帰:CML共同研究グループの調査【Powered by NICT】
Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group
著者 (14件):
Iriyama Noriyoshi
(Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan)
,
Tokuhira Michihide
(Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan)
,
Takaku Tomoiku
(Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan)
,
Sato Eriko
(Division of Hematology, Department of Medicine, Juntendo University Nerima Hospital, Tokyo, Japan)
,
Ishikawa Maho
(Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan)
,
Nakazato Tomonori
(Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan)
,
Sugimoto Kei-Ji
(Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan)
,
Fujita Hiroyuki
(Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan)
,
Fujioka Isao
(Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan)
,
Hatta Yoshihiro
(Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan)
,
Kizaki Masahiro
(Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan)
,
Komatsu Norio
(Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan)
,
Asou Norio
(Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan)
,
Kawaguchi Tatsuya
(Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan)
資料名:
Leukemia Research
(Leukemia Research)
巻:
54
ページ:
55-58
発行年:
2017年
JST資料番号:
T0017A
ISSN:
0145-2126
CODEN:
LEREDD
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)